146 research outputs found
Beyond the Angel of the North : museology and the public art cityscape in Newcastle-Gateshead
PhD ThesisThis thesis explores the ways in which museological âcollections thinkingâ can
generate new knowledge of public artâs material and cultural afterlives within a time
of increased institutional and academic interest in the aftercare and everyday use of
public art. Taking Newcastle-Gateshead (the home of the UKâs best-known public
artwork, The Angel of the North) as a case study, the thesis asks: what happens if we
examine the public art cityscape through the concepts and management principles
applied to museum collections? How might consideration of the commonalities and
tensions between museum and city-based collections offer new understandings of
permanent public artworks, and what is the relevance of this for their future
presentation and management? In bringing these museological paradigms to bear
upon public art production this thesis generates new understandings of the character
of city-based collections and the dynamics of the audience-artwork encounter as
enacted within the urban cityscape.
The thesis addresses the relevance of âcollections thinkingâ to public art in four ways.
Firstly, examining the temporal dimension, the Newcastle-Gateshead public art
cityscape exists as an unintentional collection, one that has âcrept upâ on the city over
a 55-year trajectory of commissioning activity. Looking back into this timeline,
permanent public artworks are shown as essentially time-vulnerable in both their
physical materiality and their valorisation. Secondly, looking across the cityscape, a
speculative typology of the cityâs public artworks is presented. This suggests that the
Newcastle-Gateshead collection is representative of most forms of permanent public
art practice, but can also be situated within a distinctive Northern-English culture of
post-industrial artistic production. Expanding further on the spatial dynamic of
collections, the thesis explores the comparative value and significance of public
artworks both within and outwith their relation to geographically-rooted notions of site
and place. In doing so it suggests alternative ways of constructing value around
public art, particularly in relation to artistic authorship and long-term âuse-valueâ.
Thirdly, âcollections thinkingâ engenders an original investigation of institutional
interpretive practice around public art production. This analysis shows that
iv
Newcastle-Gatesheadâs public artworks are firmly mapped within an âinterpretive
cartographyâ of artistic intention, materiality and sense of place. Finally, through an
analysis of public art audienceâs in-situ âarts talkâ (Conner 2013) the thesis argues
that public art meaning-making exists in the balance and tension between three
factors: the potentialities of the artwork; audience-held domain knowledge; and
crucially the specific âin-the-momentâ contexts of the encounter.
In examining the post-commissioning phase of public art production through these
cycles of interpretation and audiencing, and in reevaluating the relevance and
potential of museological thinking for public art practice, this thesis offers an
extension to the existing interdisciplinarity of public art research and a way of
rethinking the long-term management and curation of public art.School of Arts and Cultures (SACs) at Newcastle University for
travel and fieldwork, and of course, to the Arts and Humanities Research Council
(AHRC) who generously funded my PhD
Strange alliance or a match that was meant to be? Interrelations between public art and the museum
Cher Krause Knight  Harriet F. Senie (eds.), Museums and Public Art?. Newcastle upon Tyne: Cambridge Scholars Publishing, 2018, hardback £40, pp. xxiv+304 J Pedro Lorente, Public Art and Museums in Cultural Districts, Abingdon, New York: Routledge, 2019, hardback £115, pp.ix+22
Exploring medical student experiences of ethical issues and professionalism in Australian general practice
Delayed antibiotic prescriptions for respiratory infections
Background: Concerns exist regarding antibiotic prescribing for respiratory tract infections (RTIs) owing to adverse reactions, cost, and antibacterial resistance. One proposed strategy to reduce antibiotic prescribing is to provide prescriptions, but to advise delay in antibiotic use with the expectation that symptoms will resolve first. This is an update of a Cochrane Review originally published in 2007, and updated in 2010 and 2013. Objectives: To evaluate the effects on clinical outcomes, antibiotic use, antibiotic resistance, and patient satisfaction of advising a delayed prescription of antibiotics in respiratory tract infections. Search methods: For this 2017 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, Issue 4, 2017), which includes the Cochrane Acute Respiratory Infection Group's Specialised Register; Ovid MEDLINE (2013 to 25 May 2017); Ovid Embase (2013 to 2017 Week 21); EBSCO CINAHL Plus (1984 to 25 May 2017); Web of Science (2013 to 25 May 2017); WHO International Clinical Trials Registry Platform (1 September 2017); and ClinicalTrials.gov (1 September 2017). Selection criteria: Randomised controlled trials involving participants of all ages defined as having an RTI, where delayed antibiotics were compared to immediate antibiotics or no antibiotics. We defined a delayed antibiotic as advice to delay the filling of an antibiotic prescription by at least 48 hours. We considered all RTIs regardless of whether antibiotics were recommended or not. Data collection and analysis: We used standard Cochrane methodological procedures. Three review authors independently extracted and collated data. We assessed the risk of bias of all included trials. We contacted trial authors to obtain missing information. Main results: For this 2017 update we added one new trial involving 405 participants with uncomplicated acute respiratory infection. Overall, this review included 11 studies with a total of 3555 participants. These 11 studies involved acute respiratory infections including acute otitis media (three studies), streptococcal pharyngitis (three studies), cough (two studies), sore throat (one study), common cold (one study), and a variety of RTIs (one study). Five studies involved only children, two only adults, and four included both adults and children. Six studies were conducted in a primary care setting, three in paediatric clinics, and two in emergency departments. Studies were well reported, and appeared to be of moderate quality. Randomisation was not adequately described in two trials. Four trials blinded the outcomes assessor, and three included blinding of participants and doctors. We conducted meta-analysis for antibiotic use and patient satisfaction. We found no differences among delayed, immediate, and no prescribed antibiotics for clinical outcomes in the three studies that recruited participants with cough. For the outcome of fever with sore throat, three of the five studies favoured immediate antibiotics, and two found no difference. For the outcome of pain related to sore throat, two studies favoured immediate antibiotics, and three found no difference. One study compared delayed antibiotics with no antibiotic for sore throat, and found no difference in clinical outcomes. Three studies included participants with acute otitis media. Of the two studies with an immediate antibiotic arm, one study found no difference for fever, and the other study favoured immediate antibiotics for pain and malaise severity on Day 3. One study including participants with acute otitis media compared delayed antibiotics with no antibiotics and found no difference for pain and fever on Day 3. Two studies recruited participants with common cold. Neither study found differences for clinical outcomes between delayed and immediate antibiotic groups. One study favoured delayed antibiotics over no antibiotics for pain, fever, and cough duration (moderate quality evidence for all clinical outcomes - GRADE assessment). There were either no differences for adverse effects or results favoured delayed antibiotics over immediate antibiotics (low quality evidence - to GRADE assessment) with no significant differences in complication rates. Delayed antibiotics resulted in a significant reduction in antibiotic use compared to immediate antibiotics prescription (odds ratio (OR) 0.04, 95% confidence interval (CI) 0.03 to 0.05). However, a delayed antibiotic was more likely to result in reported antibiotic use than no antibiotics (OR 2.55, 95% CI 1.59 to 4.08) (moderate quality evidence - GRADE assessment). Patient satisfaction favoured delayed over no antibiotics (OR 1.49, 95% CI 1.08 to 2.06). There was no significant difference in patient satisfaction between delayed antibiotics and immediate antibiotics (OR 0.65, 95% CI 0.39 to 1.10) (moderate quality evidence - GRADE assessment). None of the included studies evaluated antibiotic resistance. Authors' conclusions: For many clinical outcomes, there were no differences between prescribing strategies. Symptoms for acute otitis media and sore throat were modestly improved by immediate antibiotics compared with delayed antibiotics. There were no differences in complication rates. Delaying prescribing did not result in significantly different levels of patient satisfaction compared with immediate provision of antibiotics (86% versus 91%) (moderate quality evidence). However, delay was favoured over no antibiotics (87% versus 82%). Delayed antibiotics achieved lower rates of antibiotic use compared to immediate antibiotics (31% versus 93%) (moderate quality evidence). The strategy of no antibiotics further reduced antibiotic use compared to delaying prescription for antibiotics (14% versus 28%). Delayed antibiotics for people with acute respiratory infection reduced antibiotic use compared to immediate antibiotics, but was not shown to be different to no antibiotics in terms of symptom control and disease complications. Where clinicians feel it is safe not to prescribe antibiotics immediately for people with respiratory infections, no antibiotics with advice to return if symptoms do not resolve is likely to result in the least antibiotic use while maintaining similar patient satisfaction and clinical outcomes to delaying prescription of antibiotics. Where clinicians are not confident in using a no antibiotic strategy, a delayed antibiotics strategy may be an acceptable compromise in place of immediate prescribing to significantly reduce unnecessary antibiotic use for RTIs, and thereby reduce antibiotic resistance, while maintaining patient safety and satisfaction levels. Editorial note: As a living systematic review, this review is continually updated, incorporating relevant new evidence as it becomes available. Please refer to the Cochrane Database of Systematic Reviews for the current status of this review
Exploring Medical Student Experiences of Ethical Issues and Professionalism in Australian General Practice
Student experiences of ethics and professionalism during clinical placements have a powerful influence on their future attitudes and behaviour. International literature in this area has focused predominantly on hospital placement experiences, and relied heavily on analyses of graded student essays. This study aims to explore the medical student lens on ethics and professionalism in the primary care setting, using a different method of data collection.During weekly tutorials medical students recounted, and reflected on, their general practice placement experiences. Tutors logged the ethical and professional practice issues raised by 43 students over 76 hours of tutorial time. The logs were submitted to a qualitative content analysis from which major themes emerged: mixed messages; uncertainty about professional roles; and a âmedical student predicamentâ (including unsettled boundaries, emotions and personal health concerns).Findings suggest that the extent of compromise in general practice may challenge student expectations. Students may perceive that their clinical teacher is out of step with previous teaching, especially in areas that are considered ethically grey by their teachers. Students may need support to maintain professional boundaries and personal precautions. Clinical teachers should consider exploring common ethical issues like confidentiality, writing medical certificates, professional boundaries and affordability of health care in contexts which are relevant to students. Medical students are interested in the limits and scope of professional roles. These findings provide insights for general practitioner and other practice-based clinical teachers to reflect on their ethics and professionalism teaching, mentoring and role-modelling
Antibiotics for bronchiolitis in children under two years of age (Review)
Background: Bronchiolitis is a serious, potentially life-threatening respiratory illness commonly affecting babies. It is often caused by respiratory syncytial virus (RSV). Antibiotics are not recommended for bronchiolitis unless there is concern about complications such as secondary bacterial pneumonia or respiratory failure. Nevertheless, they are often used. Objectives: To evaluate the effectiveness of antibiotics for bronchiolitis in children under two years of age compared to placebo or other interventions. Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2014, Issue 6), which includes the Cochrane Acute Respiratory Infection Group's Specialised Register, and the Database of Abstracts of Reviews of Effects, MEDLINE (1966 to June 2014), EMBASE (1990 to June 2014) and Current Contents (2001 to June 2014). Selection criteria: Randomised controlled trials (RCTs) comparing antibiotics to placebo in children under two years diagnosed with bronchiolitis, using clinical criteria (including respiratory distress preceded by coryzal symptoms with or without fever). Primary clinical outcomes included time to resolution of signs or symptoms (pulmonary markers included respiratory distress, wheeze, crepitations, oxygen saturation and fever). Secondary outcomes included hospital admissions, length of hospital stay, readmissions, complications or adverse events and radiological findings. Data collection and analysis: Two review authors independently analysed the search results. Main results: We included seven studies with a total of 824 participants. The results of these seven included studies were often heterogeneous, which generally precluded meta-analysis, except for deaths, length of supplemental oxygen use and length of hospital admission. In this update, we included two new studies (281 participants), both comparing azithromycin with placebo. They found no significant difference for length of hospital stay, duration of oxygen requirement and readmission. These results were similar to an older study (52 participants) that demonstrated no significant difference comparing ampicillin and placebo for length of illness. One small study (21 participants) with higher risk of bias randomised children with proven RSV infection to clarithromycin or placebo and found a trend towards a reduction in hospital readmission with clarithromycin. The three studies providing adequate data for days of supplementary oxygen showed no difference between antibiotics and placebo (pooled mean difference (MD) (days) -0.20; 95% confidence interval (CI) -0.72 to 0.33). The three studies providing adequate data for length of hospital stay, similarly showed no difference between antibiotics (azithromycin) and placebo (pooled MD (days) -0.58; 95% CI -1.18 to 0.02). Two studies randomised children to intravenous ampicillin, oral erythromycin and control and found no difference for most symptom measures. There were no deaths reported in any of the arms of the seven included studies. No other adverse effects were reported. Authors' conclusions: This review did not find sufficient evidence to support the use of antibiotics for bronchiolitis, although research may be justified to identify a subgroup of patients who may benefit from antibiotics. Further research may be better focused on determining the reasons that clinicians use antibiotics so readily for bronchiolitis, how to reduce their use and how to reduce clinician anxiety about not using antibiotics
Subhepatically located appendicitis due to adhesions: a case report
<p>Abstract</p> <p>Introduction</p> <p>Acute appendicitis occurs frequently and is a major indication for acute abdominal surgery. Subhepatic appendicitis has rarely been reported and is more difficult to diagnose.</p> <p>Case presentation</p> <p>A 71-year-old man with multiple medical comorbidities presented with undifferentiated right abdominal pain. Diagnostic difficulty was encountered due to subhepatic mal-location of the appendix and subsequently atypical presentation for acute appendicitis.</p> <p>Conclusion</p> <p>Subhepatic anatomical location of the appendix makes it more difficult to diagnose acute appendicitis at any age, including in older adults.</p
Smoking cessation for improving mental health
Background:
There is a common perception that smoking generally helps people to manage stress, and may be a form of 'selfâmedication' in people with mental health conditions. However, there are biologically plausible reasons why smoking may worsen mental health through neuroadaptations arising from chronic smoking, leading to frequent nicotine withdrawal symptoms (e.g. anxiety, depression, irritability), in which case smoking cessation may help to improve rather than worsen mental health.
Objectives:
To examine the association between tobacco smoking cessation and change in mental health.
Search Methods:
We searched the Cochrane Tobacco Addiction Group's Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PsycINFO, and the trial registries clinicaltrials.gov and the International Clinical Trials Registry Platform, from 14 April 2012 to 07 January 2020. These were updated searches of a previouslyâconducted nonâCochrane review where searches were conducted from database inception to 13 April 2012.
Selection Criteria:
We included controlled beforeâafter studies, including randomised controlled trials (RCTs) analysed by smoking status at followâup, and longitudinal cohort studies. In order to be eligible for inclusion studies had to recruit adults who smoked tobacco, and assess whether they quit or continued smoking during the study. They also had to measure a mental health outcome at baseline and at least six weeks later.
Data Collection and Analysis:
We followed standard Cochrane methods for screening and data extraction. Our primary outcomes were change in depression symptoms, anxiety symptoms or mixed anxiety and depression symptoms between baseline and followâup. Secondary outcomes included change in symptoms of stress, psychological quality of life, positive affect, and social impact or social quality of life, as well as new incidence of depression, anxiety, or mixed anxiety and depression disorders.
We assessed the risk of bias for the primary outcomes using a modified ROBINSâI tool. For change in mental health outcomes, we calculated the pooled standardised mean difference (SMD) and 95% confidence interval (95% CI) for the difference in change in mental health from baseline to followâup between those who had quit smoking and those who had continued to smoke. For the incidence of psychological disorders, we calculated odds ratios (ORs) and 95% CIs. For all metaâanalyses we used a generic inverse variance randomâeffects model and quantified statistical heterogeneity using I2. We conducted subgroup analyses to investigate any differences in associations between subâpopulations, i.e. unselected people with mental illness, people with physical chronic diseases.
We assessed the certainty of evidence for our primary outcomes (depression, anxiety, and mixed depression and anxiety) and our secondary social impact outcome using the eight GRADE considerations relevant to nonârandomised studies (risk of bias, inconsistency, imprecision, indirectness, publication bias, magnitude of the effect, the influence of all plausible residual confounding, the presence of a doseâresponse gradient).
Main Results:
We included 102 studies representing over 169,500 participants. Sixtyâtwo of these were identified in the updated search for this review and 40 were included in the original version of the review. Sixtyâthree studies provided data on change in mental health, 10 were included in metaâanalyses of incidence of mental health disorders, and 31 were synthesised narratively.
For all primary outcomes, smoking cessation was associated with an improvement in mental health symptoms compared with continuing to smoke: anxiety symptoms (SMD â0.28, 95% CI â0.43 to â0.13; 15 studies, 3141 participants; I2 = 69%; lowâcertainty evidence); depression symptoms: (SMD â0.30, 95% CI â0.39 to â0.21; 34 studies, 7156 participants; I2 = 69%' very lowâcertainty evidence); mixed anxiety and depression symptoms (SMD â0.31, 95% CI â0.40 to â0.22; 8 studies, 2829 participants; I2 = 0%; moderate certainty evidence). These findings were robust to preplanned sensitivity analyses, and subgroup analysis generally did not produce evidence of differences in the effect size among subpopulations or based on methodological characteristics. All studies were deemed to be at serious risk of bias due to possible timeâvarying confounding, and three studies measuring depression symptoms were judged to be at critical risk of bias overall. There was also some evidence of funnel plot asymmetry. For these reasons, we rated our certainty in the estimates for anxiety as low, for depression as very low, and for mixed anxiety and depression as moderate.
For the secondary outcomes, smoking cessation was associated with an improvement in symptoms of stress (SMD â0.19, 95% CI â0.34 to â0.04; 4 studies, 1792 participants; I2 = 50%), positive affect (SMD 0.22, 95% CI 0.11 to 0.33; 13 studies, 4880 participants; I2 = 75%), and psychological quality of life (SMD 0.11, 95% CI 0.06 to 0.16; 19 studies, 18,034 participants; I2 = 42%). There was also evidence that smoking cessation was not associated with a reduction in social quality of life, with the confidence interval incorporating the possibility of a small improvement (SMD 0.03, 95% CI 0.00 to 0.06; 9 studies, 14,673 participants; I2 = 0%). The incidence of new mixed anxiety and depression was lower in people who stopped smoking compared with those who continued (OR 0.76, 95% CI 0.66 to 0.86; 3 studies, 8685 participants; I2 = 57%), as was the incidence of anxiety disorder (OR 0.61, 95% CI 0.34 to 1.12; 2 studies, 2293 participants; I2 = 46%). We deemed it inappropriate to present a pooled estimate for the incidence of new cases of clinical depression, as there was high statistical heterogeneity (I2 = 87%).
Authors' Conclusions:
Taken together, these data provide evidence that mental health does not worsen as a result of quitting smoking, and very lowâ to moderateâcertainty evidence that smoking cessation is associated with small to moderate improvements in mental health. These improvements are seen in both unselected samples and in subpopulations, including people diagnosed with mental health conditions. Additional studies that use more advanced methods to overcome timeâvarying confounding would strengthen the evidence in this area.</p
- âŠ